nodes	percent_of_prediction	percent_of_DWPC	metapath
Granisetron—CYP1A1—liver cancer	0.679	1	CbGaD
Granisetron—CYP3A5—Sorafenib—liver cancer	0.0566	0.383	CbGbCtD
Granisetron—CYP2D6—Sorafenib—liver cancer	0.0347	0.235	CbGbCtD
Granisetron—CYP3A4—Sorafenib—liver cancer	0.0221	0.149	CbGbCtD
Granisetron—CYP2D6—Doxorubicin—liver cancer	0.0211	0.142	CbGbCtD
Granisetron—CYP3A4—Doxorubicin—liver cancer	0.0134	0.0906	CbGbCtD
Granisetron—Generalised oedema—Epirubicin—liver cancer	0.00115	0.0103	CcSEcCtD
Granisetron—Enlargement abdomen—Epirubicin—liver cancer	0.00113	0.0102	CcSEcCtD
Granisetron—Generalised oedema—Doxorubicin—liver cancer	0.00106	0.00951	CcSEcCtD
Granisetron—Enlargement abdomen—Doxorubicin—liver cancer	0.00105	0.0094	CcSEcCtD
Granisetron—Jaundice—Sorafenib—liver cancer	0.00101	0.00902	CcSEcCtD
Granisetron—Hepatobiliary disease—Sorafenib—liver cancer	0.000977	0.00875	CcSEcCtD
Granisetron—Epistaxis—Sorafenib—liver cancer	0.000974	0.00873	CcSEcCtD
Granisetron—Ileus—Epirubicin—liver cancer	0.000964	0.00863	CcSEcCtD
Granisetron—Ventricular arrhythmia—Epirubicin—liver cancer	0.000922	0.00826	CcSEcCtD
Granisetron—Connective tissue disorder—Sorafenib—liver cancer	0.000911	0.00816	CcSEcCtD
Granisetron—Ileus—Doxorubicin—liver cancer	0.000892	0.00799	CcSEcCtD
Granisetron—Flushing—Sorafenib—liver cancer	0.00086	0.00771	CcSEcCtD
Granisetron—Ventricular arrhythmia—Doxorubicin—liver cancer	0.000853	0.00764	CcSEcCtD
Granisetron—Angiopathy—Sorafenib—liver cancer	0.000841	0.00753	CcSEcCtD
Granisetron—Arrhythmia—Sorafenib—liver cancer	0.000828	0.00742	CcSEcCtD
Granisetron—Alopecia—Sorafenib—liver cancer	0.000819	0.00734	CcSEcCtD
Granisetron—Liver injury—Epirubicin—liver cancer	0.000811	0.00726	CcSEcCtD
Granisetron—Malnutrition—Sorafenib—liver cancer	0.000807	0.00723	CcSEcCtD
Granisetron—Dysgeusia—Sorafenib—liver cancer	0.00079	0.00708	CcSEcCtD
Granisetron—Ventricular extrasystoles—Epirubicin—liver cancer	0.000755	0.00677	CcSEcCtD
Granisetron—Hyperbilirubinaemia—Epirubicin—liver cancer	0.00075	0.00672	CcSEcCtD
Granisetron—Liver injury—Doxorubicin—liver cancer	0.00075	0.00672	CcSEcCtD
Granisetron—Anaemia—Sorafenib—liver cancer	0.000746	0.00668	CcSEcCtD
Granisetron—Oliguria—Epirubicin—liver cancer	0.00074	0.00663	CcSEcCtD
Granisetron—Dyskinesia—Epirubicin—liver cancer	0.000726	0.0065	CcSEcCtD
Granisetron—Syncope—Sorafenib—liver cancer	0.000724	0.00648	CcSEcCtD
Granisetron—Leukopenia—Sorafenib—liver cancer	0.000722	0.00647	CcSEcCtD
Granisetron—Loss of consciousness—Sorafenib—liver cancer	0.000709	0.00635	CcSEcCtD
Granisetron—Cough—Sorafenib—liver cancer	0.000704	0.00631	CcSEcCtD
Granisetron—Atrioventricular block—Epirubicin—liver cancer	0.000703	0.0063	CcSEcCtD
Granisetron—Ventricular extrasystoles—Doxorubicin—liver cancer	0.000699	0.00626	CcSEcCtD
Granisetron—Hypertension—Sorafenib—liver cancer	0.000697	0.00624	CcSEcCtD
Granisetron—Hyperbilirubinaemia—Doxorubicin—liver cancer	0.000694	0.00622	CcSEcCtD
Granisetron—Arthralgia—Sorafenib—liver cancer	0.000687	0.00615	CcSEcCtD
Granisetron—Oliguria—Doxorubicin—liver cancer	0.000685	0.00614	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000682	0.00611	CcSEcCtD
Granisetron—Hepatocellular injury—Epirubicin—liver cancer	0.000682	0.00611	CcSEcCtD
Granisetron—Hiccups—Epirubicin—liver cancer	0.000682	0.00611	CcSEcCtD
Granisetron—Dry mouth—Sorafenib—liver cancer	0.000672	0.00602	CcSEcCtD
Granisetron—Dyskinesia—Doxorubicin—liver cancer	0.000672	0.00602	CcSEcCtD
Granisetron—Melaena—Epirubicin—liver cancer	0.000666	0.00597	CcSEcCtD
Granisetron—Anaphylactic shock—Sorafenib—liver cancer	0.000659	0.0059	CcSEcCtD
Granisetron—Infection—Sorafenib—liver cancer	0.000654	0.00586	CcSEcCtD
Granisetron—Atrioventricular block—Doxorubicin—liver cancer	0.000651	0.00583	CcSEcCtD
Granisetron—Shock—Sorafenib—liver cancer	0.000648	0.0058	CcSEcCtD
Granisetron—Fluid retention—Epirubicin—liver cancer	0.000648	0.0058	CcSEcCtD
Granisetron—Nervous system disorder—Sorafenib—liver cancer	0.000646	0.00579	CcSEcCtD
Granisetron—Thrombocytopenia—Sorafenib—liver cancer	0.000645	0.00578	CcSEcCtD
Granisetron—Skin disorder—Sorafenib—liver cancer	0.00064	0.00573	CcSEcCtD
Granisetron—Hepatocellular injury—Doxorubicin—liver cancer	0.000631	0.00565	CcSEcCtD
Granisetron—Hiccups—Doxorubicin—liver cancer	0.000631	0.00565	CcSEcCtD
Granisetron—Coma—Epirubicin—liver cancer	0.000623	0.00558	CcSEcCtD
Granisetron—Melaena—Doxorubicin—liver cancer	0.000617	0.00552	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Sorafenib—liver cancer	0.0006	0.00538	CcSEcCtD
Granisetron—Fluid retention—Doxorubicin—liver cancer	0.000599	0.00537	CcSEcCtD
Granisetron—Abnormal vision—Epirubicin—liver cancer	0.000595	0.00533	CcSEcCtD
Granisetron—Dyspnoea—Sorafenib—liver cancer	0.000587	0.00526	CcSEcCtD
Granisetron—Dyspepsia—Sorafenib—liver cancer	0.00058	0.00519	CcSEcCtD
Granisetron—Coma—Doxorubicin—liver cancer	0.000577	0.00517	CcSEcCtD
Granisetron—Decreased appetite—Sorafenib—liver cancer	0.000573	0.00513	CcSEcCtD
Granisetron—Gastrointestinal disorder—Sorafenib—liver cancer	0.000569	0.00509	CcSEcCtD
Granisetron—Photosensitivity—Epirubicin—liver cancer	0.000564	0.00505	CcSEcCtD
Granisetron—Constipation—Sorafenib—liver cancer	0.000563	0.00505	CcSEcCtD
Granisetron—Pain—Sorafenib—liver cancer	0.000563	0.00505	CcSEcCtD
Granisetron—Abnormal vision—Doxorubicin—liver cancer	0.000551	0.00493	CcSEcCtD
Granisetron—Gastrointestinal pain—Sorafenib—liver cancer	0.000539	0.00482	CcSEcCtD
Granisetron—Urticaria—Sorafenib—liver cancer	0.000523	0.00469	CcSEcCtD
Granisetron—Photosensitivity—Doxorubicin—liver cancer	0.000522	0.00467	CcSEcCtD
Granisetron—Abdominal pain—Sorafenib—liver cancer	0.000521	0.00466	CcSEcCtD
Granisetron—Body temperature increased—Sorafenib—liver cancer	0.000521	0.00466	CcSEcCtD
Granisetron—Hyponatraemia—Epirubicin—liver cancer	0.000497	0.00445	CcSEcCtD
Granisetron—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.000495	0.00444	CcSEcCtD
Granisetron—Migraine—Epirubicin—liver cancer	0.000488	0.00437	CcSEcCtD
Granisetron—Hypersensitivity—Sorafenib—liver cancer	0.000485	0.00435	CcSEcCtD
Granisetron—Asthenia—Sorafenib—liver cancer	0.000473	0.00423	CcSEcCtD
Granisetron—Pruritus—Sorafenib—liver cancer	0.000466	0.00417	CcSEcCtD
Granisetron—Hyponatraemia—Doxorubicin—liver cancer	0.00046	0.00412	CcSEcCtD
Granisetron—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.000458	0.0041	CcSEcCtD
Granisetron—Liver function test abnormal—Epirubicin—liver cancer	0.000457	0.0041	CcSEcCtD
Granisetron—Orthostatic hypotension—Epirubicin—liver cancer	0.000452	0.00405	CcSEcCtD
Granisetron—Migraine—Doxorubicin—liver cancer	0.000451	0.00404	CcSEcCtD
Granisetron—Hypokalaemia—Epirubicin—liver cancer	0.000451	0.00404	CcSEcCtD
Granisetron—Diarrhoea—Sorafenib—liver cancer	0.000451	0.00404	CcSEcCtD
Granisetron—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000446	0.00399	CcSEcCtD
Granisetron—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000437	0.00391	CcSEcCtD
Granisetron—Dizziness—Sorafenib—liver cancer	0.000436	0.0039	CcSEcCtD
Granisetron—Abdominal distension—Epirubicin—liver cancer	0.000431	0.00386	CcSEcCtD
Granisetron—Eosinophilia—Epirubicin—liver cancer	0.000424	0.0038	CcSEcCtD
Granisetron—Liver function test abnormal—Doxorubicin—liver cancer	0.000423	0.00379	CcSEcCtD
Granisetron—Vomiting—Sorafenib—liver cancer	0.000419	0.00375	CcSEcCtD
Granisetron—Orthostatic hypotension—Doxorubicin—liver cancer	0.000419	0.00375	CcSEcCtD
Granisetron—Hypokalaemia—Doxorubicin—liver cancer	0.000417	0.00374	CcSEcCtD
Granisetron—Angina pectoris—Epirubicin—liver cancer	0.000417	0.00373	CcSEcCtD
Granisetron—Rash—Sorafenib—liver cancer	0.000415	0.00372	CcSEcCtD
Granisetron—Dermatitis—Sorafenib—liver cancer	0.000415	0.00372	CcSEcCtD
Granisetron—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000413	0.0037	CcSEcCtD
Granisetron—Headache—Sorafenib—liver cancer	0.000413	0.0037	CcSEcCtD
Granisetron—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000404	0.00362	CcSEcCtD
Granisetron—Dysuria—Epirubicin—liver cancer	0.0004	0.00359	CcSEcCtD
Granisetron—Abdominal distension—Doxorubicin—liver cancer	0.000399	0.00357	CcSEcCtD
Granisetron—Eosinophilia—Doxorubicin—liver cancer	0.000392	0.00351	CcSEcCtD
Granisetron—Nausea—Sorafenib—liver cancer	0.000391	0.0035	CcSEcCtD
Granisetron—Photosensitivity reaction—Epirubicin—liver cancer	0.000391	0.0035	CcSEcCtD
Granisetron—Angina pectoris—Doxorubicin—liver cancer	0.000386	0.00346	CcSEcCtD
Granisetron—Jaundice—Epirubicin—liver cancer	0.000372	0.00333	CcSEcCtD
Granisetron—Urinary tract infection—Epirubicin—liver cancer	0.000371	0.00332	CcSEcCtD
Granisetron—Dysuria—Doxorubicin—liver cancer	0.00037	0.00332	CcSEcCtD
Granisetron—Sweating—Epirubicin—liver cancer	0.000366	0.00328	CcSEcCtD
Granisetron—Photosensitivity reaction—Doxorubicin—liver cancer	0.000362	0.00324	CcSEcCtD
Granisetron—Hepatobiliary disease—Epirubicin—liver cancer	0.000361	0.00323	CcSEcCtD
Granisetron—Epistaxis—Epirubicin—liver cancer	0.00036	0.00322	CcSEcCtD
Granisetron—Sinusitis—Epirubicin—liver cancer	0.000358	0.00321	CcSEcCtD
Granisetron—Bradycardia—Epirubicin—liver cancer	0.000349	0.00312	CcSEcCtD
Granisetron—Jaundice—Doxorubicin—liver cancer	0.000344	0.00308	CcSEcCtD
Granisetron—Rhinitis—Epirubicin—liver cancer	0.000344	0.00308	CcSEcCtD
Granisetron—Urinary tract infection—Doxorubicin—liver cancer	0.000343	0.00307	CcSEcCtD
Granisetron—Sweating—Doxorubicin—liver cancer	0.000339	0.00303	CcSEcCtD
Granisetron—Connective tissue disorder—Epirubicin—liver cancer	0.000337	0.00302	CcSEcCtD
Granisetron—Hepatobiliary disease—Doxorubicin—liver cancer	0.000334	0.00299	CcSEcCtD
Granisetron—Epistaxis—Doxorubicin—liver cancer	0.000333	0.00298	CcSEcCtD
Granisetron—Sinusitis—Doxorubicin—liver cancer	0.000331	0.00297	CcSEcCtD
Granisetron—Visual impairment—Epirubicin—liver cancer	0.00033	0.00296	CcSEcCtD
Granisetron—Bradycardia—Doxorubicin—liver cancer	0.000323	0.00289	CcSEcCtD
Granisetron—Flushing—Epirubicin—liver cancer	0.000318	0.00285	CcSEcCtD
Granisetron—Rhinitis—Doxorubicin—liver cancer	0.000318	0.00285	CcSEcCtD
Granisetron—Connective tissue disorder—Doxorubicin—liver cancer	0.000312	0.00279	CcSEcCtD
Granisetron—Angiopathy—Epirubicin—liver cancer	0.000311	0.00278	CcSEcCtD
Granisetron—Chills—Epirubicin—liver cancer	0.000307	0.00275	CcSEcCtD
Granisetron—Arrhythmia—Epirubicin—liver cancer	0.000306	0.00274	CcSEcCtD
Granisetron—Visual impairment—Doxorubicin—liver cancer	0.000306	0.00274	CcSEcCtD
Granisetron—Alopecia—Epirubicin—liver cancer	0.000303	0.00271	CcSEcCtD
Granisetron—Malnutrition—Epirubicin—liver cancer	0.000298	0.00267	CcSEcCtD
Granisetron—Flushing—Doxorubicin—liver cancer	0.000294	0.00264	CcSEcCtD
Granisetron—Flatulence—Epirubicin—liver cancer	0.000294	0.00263	CcSEcCtD
Granisetron—Tension—Epirubicin—liver cancer	0.000293	0.00262	CcSEcCtD
Granisetron—Dysgeusia—Epirubicin—liver cancer	0.000292	0.00262	CcSEcCtD
Granisetron—Nervousness—Epirubicin—liver cancer	0.00029	0.00259	CcSEcCtD
Granisetron—Angiopathy—Doxorubicin—liver cancer	0.000288	0.00258	CcSEcCtD
Granisetron—Chills—Doxorubicin—liver cancer	0.000284	0.00255	CcSEcCtD
Granisetron—Arrhythmia—Doxorubicin—liver cancer	0.000283	0.00254	CcSEcCtD
Granisetron—Alopecia—Doxorubicin—liver cancer	0.00028	0.00251	CcSEcCtD
Granisetron—Ill-defined disorder—Epirubicin—liver cancer	0.000277	0.00248	CcSEcCtD
Granisetron—Malnutrition—Doxorubicin—liver cancer	0.000276	0.00247	CcSEcCtD
Granisetron—Anaemia—Epirubicin—liver cancer	0.000276	0.00247	CcSEcCtD
Granisetron—Agitation—Epirubicin—liver cancer	0.000274	0.00246	CcSEcCtD
Granisetron—Flatulence—Doxorubicin—liver cancer	0.000272	0.00244	CcSEcCtD
Granisetron—Tension—Doxorubicin—liver cancer	0.000271	0.00243	CcSEcCtD
Granisetron—Dysgeusia—Doxorubicin—liver cancer	0.00027	0.00242	CcSEcCtD
Granisetron—Malaise—Epirubicin—liver cancer	0.000269	0.00241	CcSEcCtD
Granisetron—Nervousness—Doxorubicin—liver cancer	0.000268	0.0024	CcSEcCtD
Granisetron—Vertigo—Epirubicin—liver cancer	0.000268	0.0024	CcSEcCtD
Granisetron—Syncope—Epirubicin—liver cancer	0.000267	0.0024	CcSEcCtD
Granisetron—Leukopenia—Epirubicin—liver cancer	0.000267	0.00239	CcSEcCtD
Granisetron—Palpitations—Epirubicin—liver cancer	0.000264	0.00236	CcSEcCtD
Granisetron—Loss of consciousness—Epirubicin—liver cancer	0.000262	0.00235	CcSEcCtD
Granisetron—Cough—Epirubicin—liver cancer	0.00026	0.00233	CcSEcCtD
Granisetron—Hypertension—Epirubicin—liver cancer	0.000258	0.00231	CcSEcCtD
Granisetron—Ill-defined disorder—Doxorubicin—liver cancer	0.000256	0.00229	CcSEcCtD
Granisetron—Anaemia—Doxorubicin—liver cancer	0.000255	0.00228	CcSEcCtD
Granisetron—Arthralgia—Epirubicin—liver cancer	0.000254	0.00227	CcSEcCtD
Granisetron—Chest pain—Epirubicin—liver cancer	0.000254	0.00227	CcSEcCtD
Granisetron—Agitation—Doxorubicin—liver cancer	0.000254	0.00227	CcSEcCtD
Granisetron—Anxiety—Epirubicin—liver cancer	0.000253	0.00227	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000252	0.00226	CcSEcCtD
Granisetron—Discomfort—Epirubicin—liver cancer	0.000251	0.00225	CcSEcCtD
Granisetron—Malaise—Doxorubicin—liver cancer	0.000249	0.00223	CcSEcCtD
Granisetron—Dry mouth—Epirubicin—liver cancer	0.000248	0.00222	CcSEcCtD
Granisetron—Vertigo—Doxorubicin—liver cancer	0.000248	0.00222	CcSEcCtD
Granisetron—Syncope—Doxorubicin—liver cancer	0.000247	0.00222	CcSEcCtD
Granisetron—Leukopenia—Doxorubicin—liver cancer	0.000247	0.00221	CcSEcCtD
Granisetron—Palpitations—Doxorubicin—liver cancer	0.000244	0.00218	CcSEcCtD
Granisetron—Anaphylactic shock—Epirubicin—liver cancer	0.000243	0.00218	CcSEcCtD
Granisetron—Oedema—Epirubicin—liver cancer	0.000243	0.00218	CcSEcCtD
Granisetron—Loss of consciousness—Doxorubicin—liver cancer	0.000243	0.00217	CcSEcCtD
Granisetron—Infection—Epirubicin—liver cancer	0.000242	0.00217	CcSEcCtD
Granisetron—Cough—Doxorubicin—liver cancer	0.000241	0.00216	CcSEcCtD
Granisetron—Shock—Epirubicin—liver cancer	0.000239	0.00215	CcSEcCtD
Granisetron—Nervous system disorder—Epirubicin—liver cancer	0.000239	0.00214	CcSEcCtD
Granisetron—Thrombocytopenia—Epirubicin—liver cancer	0.000238	0.00213	CcSEcCtD
Granisetron—Hypertension—Doxorubicin—liver cancer	0.000238	0.00213	CcSEcCtD
Granisetron—Tachycardia—Epirubicin—liver cancer	0.000238	0.00213	CcSEcCtD
Granisetron—Skin disorder—Epirubicin—liver cancer	0.000236	0.00212	CcSEcCtD
Granisetron—Hyperhidrosis—Epirubicin—liver cancer	0.000235	0.00211	CcSEcCtD
Granisetron—Arthralgia—Doxorubicin—liver cancer	0.000235	0.0021	CcSEcCtD
Granisetron—Chest pain—Doxorubicin—liver cancer	0.000235	0.0021	CcSEcCtD
Granisetron—Anxiety—Doxorubicin—liver cancer	0.000234	0.0021	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000233	0.00209	CcSEcCtD
Granisetron—Discomfort—Doxorubicin—liver cancer	0.000232	0.00208	CcSEcCtD
Granisetron—Dry mouth—Doxorubicin—liver cancer	0.00023	0.00206	CcSEcCtD
Granisetron—Hypotension—Epirubicin—liver cancer	0.000227	0.00204	CcSEcCtD
Granisetron—Anaphylactic shock—Doxorubicin—liver cancer	0.000225	0.00202	CcSEcCtD
Granisetron—Oedema—Doxorubicin—liver cancer	0.000225	0.00202	CcSEcCtD
Granisetron—Infection—Doxorubicin—liver cancer	0.000224	0.002	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000222	0.00199	CcSEcCtD
Granisetron—Shock—Doxorubicin—liver cancer	0.000222	0.00198	CcSEcCtD
Granisetron—Nervous system disorder—Doxorubicin—liver cancer	0.000221	0.00198	CcSEcCtD
Granisetron—Thrombocytopenia—Doxorubicin—liver cancer	0.000221	0.00198	CcSEcCtD
Granisetron—Insomnia—Epirubicin—liver cancer	0.00022	0.00197	CcSEcCtD
Granisetron—Tachycardia—Doxorubicin—liver cancer	0.00022	0.00197	CcSEcCtD
Granisetron—Skin disorder—Doxorubicin—liver cancer	0.000219	0.00196	CcSEcCtD
Granisetron—Paraesthesia—Epirubicin—liver cancer	0.000219	0.00196	CcSEcCtD
Granisetron—Hyperhidrosis—Doxorubicin—liver cancer	0.000218	0.00195	CcSEcCtD
Granisetron—Dyspnoea—Epirubicin—liver cancer	0.000217	0.00194	CcSEcCtD
Granisetron—Somnolence—Epirubicin—liver cancer	0.000216	0.00194	CcSEcCtD
Granisetron—Dyspepsia—Epirubicin—liver cancer	0.000214	0.00192	CcSEcCtD
Granisetron—Decreased appetite—Epirubicin—liver cancer	0.000212	0.0019	CcSEcCtD
Granisetron—Hypotension—Doxorubicin—liver cancer	0.00021	0.00189	CcSEcCtD
Granisetron—Gastrointestinal disorder—Epirubicin—liver cancer	0.00021	0.00188	CcSEcCtD
Granisetron—Pain—Epirubicin—liver cancer	0.000208	0.00186	CcSEcCtD
Granisetron—Constipation—Epirubicin—liver cancer	0.000208	0.00186	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000205	0.00184	CcSEcCtD
Granisetron—Insomnia—Doxorubicin—liver cancer	0.000204	0.00182	CcSEcCtD
Granisetron—Paraesthesia—Doxorubicin—liver cancer	0.000202	0.00181	CcSEcCtD
Granisetron—Dyspnoea—Doxorubicin—liver cancer	0.000201	0.0018	CcSEcCtD
Granisetron—Feeling abnormal—Epirubicin—liver cancer	0.000201	0.0018	CcSEcCtD
Granisetron—Somnolence—Doxorubicin—liver cancer	0.0002	0.00179	CcSEcCtD
Granisetron—Gastrointestinal pain—Epirubicin—liver cancer	0.000199	0.00178	CcSEcCtD
Granisetron—Dyspepsia—Doxorubicin—liver cancer	0.000198	0.00178	CcSEcCtD
Granisetron—Decreased appetite—Doxorubicin—liver cancer	0.000196	0.00175	CcSEcCtD
Granisetron—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000194	0.00174	CcSEcCtD
Granisetron—Urticaria—Epirubicin—liver cancer	0.000193	0.00173	CcSEcCtD
Granisetron—Constipation—Doxorubicin—liver cancer	0.000193	0.00173	CcSEcCtD
Granisetron—Pain—Doxorubicin—liver cancer	0.000193	0.00173	CcSEcCtD
Granisetron—Body temperature increased—Epirubicin—liver cancer	0.000192	0.00172	CcSEcCtD
Granisetron—Abdominal pain—Epirubicin—liver cancer	0.000192	0.00172	CcSEcCtD
Granisetron—Feeling abnormal—Doxorubicin—liver cancer	0.000186	0.00166	CcSEcCtD
Granisetron—Gastrointestinal pain—Doxorubicin—liver cancer	0.000184	0.00165	CcSEcCtD
Granisetron—Hypersensitivity—Epirubicin—liver cancer	0.000179	0.00161	CcSEcCtD
Granisetron—Urticaria—Doxorubicin—liver cancer	0.000179	0.0016	CcSEcCtD
Granisetron—Abdominal pain—Doxorubicin—liver cancer	0.000178	0.00159	CcSEcCtD
Granisetron—Body temperature increased—Doxorubicin—liver cancer	0.000178	0.00159	CcSEcCtD
Granisetron—Asthenia—Epirubicin—liver cancer	0.000175	0.00156	CcSEcCtD
Granisetron—Pruritus—Epirubicin—liver cancer	0.000172	0.00154	CcSEcCtD
Granisetron—Diarrhoea—Epirubicin—liver cancer	0.000167	0.00149	CcSEcCtD
Granisetron—Hypersensitivity—Doxorubicin—liver cancer	0.000166	0.00149	CcSEcCtD
Granisetron—Asthenia—Doxorubicin—liver cancer	0.000162	0.00145	CcSEcCtD
Granisetron—Dizziness—Epirubicin—liver cancer	0.000161	0.00144	CcSEcCtD
Granisetron—Pruritus—Doxorubicin—liver cancer	0.000159	0.00143	CcSEcCtD
Granisetron—HTR3A—SIDS Susceptibility Pathways—JUN—liver cancer	0.000158	0.00258	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—CTNNB1—liver cancer	0.000157	0.00256	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—NR1H4—liver cancer	0.000155	0.00254	CbGpPWpGaD
Granisetron—Vomiting—Epirubicin—liver cancer	0.000155	0.00139	CcSEcCtD
Granisetron—Diarrhoea—Doxorubicin—liver cancer	0.000154	0.00138	CcSEcCtD
Granisetron—Rash—Epirubicin—liver cancer	0.000153	0.00137	CcSEcCtD
Granisetron—Dermatitis—Epirubicin—liver cancer	0.000153	0.00137	CcSEcCtD
Granisetron—CYP3A5—Metapathway biotransformation—GPX3—liver cancer	0.000153	0.0025	CbGpPWpGaD
Granisetron—Headache—Epirubicin—liver cancer	0.000152	0.00137	CcSEcCtD
Granisetron—CYP2D6—Biological oxidations—GSTA3—liver cancer	0.000152	0.00249	CbGpPWpGaD
Granisetron—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—liver cancer	0.000152	0.00248	CbGpPWpGaD
Granisetron—CYP2D6—Metapathway biotransformation—GSTA3—liver cancer	0.00015	0.00246	CbGpPWpGaD
Granisetron—Dizziness—Doxorubicin—liver cancer	0.000149	0.00133	CcSEcCtD
Granisetron—CYP3A5—Biological oxidations—HPGDS—liver cancer	0.000146	0.00238	CbGpPWpGaD
Granisetron—Nausea—Epirubicin—liver cancer	0.000145	0.0013	CcSEcCtD
Granisetron—CYP1A1—Metapathway biotransformation—GPX3—liver cancer	0.000144	0.00236	CbGpPWpGaD
Granisetron—Vomiting—Doxorubicin—liver cancer	0.000143	0.00128	CcSEcCtD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—RAF1—liver cancer	0.000142	0.00233	CbGpPWpGaD
Granisetron—Rash—Doxorubicin—liver cancer	0.000142	0.00127	CcSEcCtD
Granisetron—Dermatitis—Doxorubicin—liver cancer	0.000142	0.00127	CcSEcCtD
Granisetron—Headache—Doxorubicin—liver cancer	0.000141	0.00126	CcSEcCtD
Granisetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000141	0.00231	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—GSTA4—liver cancer	0.000139	0.00228	CbGpPWpGaD
Granisetron—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000139	0.00227	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—VEGFA—liver cancer	0.000138	0.00226	CbGpPWpGaD
Granisetron—CYP1A1—Biological oxidations—HPGDS—liver cancer	0.000137	0.00225	CbGpPWpGaD
Granisetron—CYP2D6—Metapathway biotransformation—GSTA4—liver cancer	0.000137	0.00225	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—GSTA2—liver cancer	0.000136	0.00222	CbGpPWpGaD
Granisetron—Nausea—Doxorubicin—liver cancer	0.000134	0.0012	CcSEcCtD
Granisetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.000133	0.00217	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—GSTA1—liver cancer	0.000131	0.00214	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—liver cancer	0.00013	0.00213	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—liver cancer	0.00013	0.00213	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—NAT2—liver cancer	0.000129	0.00212	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—CYCS—liver cancer	0.000129	0.00212	CbGpPWpGaD
Granisetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000128	0.0021	CbGpPWpGaD
Granisetron—CYP2D6—Metapathway biotransformation—NAT2—liver cancer	0.000128	0.00209	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—liver cancer	0.000127	0.00209	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.000127	0.00208	CbGpPWpGaD
Granisetron—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000126	0.00207	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—liver cancer	0.000124	0.00203	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1A—liver cancer	0.00012	0.00197	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—CYP2E1—liver cancer	0.000119	0.00194	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—TNF—liver cancer	0.000118	0.00193	CbGpPWpGaD
Granisetron—CYP3A5—Metapathway biotransformation—CYP2E1—liver cancer	0.000117	0.00192	CbGpPWpGaD
Granisetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000114	0.00187	CbGpPWpGaD
Granisetron—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.000114	0.00186	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000112	0.00184	CbGpPWpGaD
Granisetron—CYP1A1—Biological oxidations—CYP2E1—liver cancer	0.000112	0.00184	CbGpPWpGaD
Granisetron—CYP1A1—Metapathway biotransformation—CYP2E1—liver cancer	0.000111	0.00181	CbGpPWpGaD
Granisetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.00011	0.00179	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—GGT1—liver cancer	0.000109	0.00178	CbGpPWpGaD
Granisetron—CYP2D6—Metapathway biotransformation—GPX3—liver cancer	0.000109	0.00178	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—liver cancer	0.000108	0.00177	CbGpPWpGaD
Granisetron—CYP1A1—PPARA activates gene expression—PPARA—liver cancer	0.000105	0.00172	CbGpPWpGaD
Granisetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000104	0.0017	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—HPGDS—liver cancer	0.000103	0.00169	CbGpPWpGaD
Granisetron—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARA—liver cancer	0.000103	0.00169	CbGpPWpGaD
Granisetron—CYP1A1—Biological oxidations—GGT1—liver cancer	0.000103	0.00169	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.000101	0.00166	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—MYC—liver cancer	9.97e-05	0.00163	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—GSTA3—liver cancer	9.95e-05	0.00163	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—liver cancer	9.94e-05	0.00163	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	9.82e-05	0.00161	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—GSTP1—liver cancer	9.78e-05	0.0016	CbGpPWpGaD
Granisetron—CYP3A5—Metapathway biotransformation—GSTP1—liver cancer	9.65e-05	0.00158	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—IL6—liver cancer	9.53e-05	0.00156	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—liver cancer	9.28e-05	0.00152	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—TNF—liver cancer	9.28e-05	0.00152	CbGpPWpGaD
Granisetron—CYP1A1—Biological oxidations—GSTP1—liver cancer	9.24e-05	0.00151	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—liver cancer	9.21e-05	0.00151	CbGpPWpGaD
Granisetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	9.2e-05	0.00151	CbGpPWpGaD
Granisetron—CYP1A1—Metapathway biotransformation—GSTP1—liver cancer	9.12e-05	0.00149	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—GSTA4—liver cancer	9.1e-05	0.00149	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—PPARA—liver cancer	9.09e-05	0.00149	CbGpPWpGaD
Granisetron—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	9.08e-05	0.00149	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—GSTM1—liver cancer	8.99e-05	0.00147	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	8.98e-05	0.00147	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—GSTA2—liver cancer	8.87e-05	0.00145	CbGpPWpGaD
Granisetron—CYP3A5—Metapathway biotransformation—GSTM1—liver cancer	8.87e-05	0.00145	CbGpPWpGaD
Granisetron—CYP1A1—PPARA activates gene expression—PPARG—liver cancer	8.7e-05	0.00143	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—GSTA1—liver cancer	8.56e-05	0.0014	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—CYP1A1—liver cancer	8.52e-05	0.0014	CbGpPWpGaD
Granisetron—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—liver cancer	8.52e-05	0.0014	CbGpPWpGaD
Granisetron—CYP1A1—Biological oxidations—GSTM1—liver cancer	8.49e-05	0.00139	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—NAT2—liver cancer	8.46e-05	0.00139	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—CYP2E1—liver cancer	8.43e-05	0.00138	CbGpPWpGaD
Granisetron—CYP3A5—Metapathway biotransformation—CYP1A1—liver cancer	8.41e-05	0.00138	CbGpPWpGaD
Granisetron—CYP1A1—Metapathway biotransformation—GSTM1—liver cancer	8.38e-05	0.00137	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	8.35e-05	0.00137	CbGpPWpGaD
Granisetron—CYP2D6—Metapathway biotransformation—CYP2E1—liver cancer	8.32e-05	0.00136	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	8.19e-05	0.00134	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	7.9e-05	0.00129	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—liver cancer	7.83e-05	0.00128	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—GGT1—liver cancer	7.74e-05	0.00127	CbGpPWpGaD
Granisetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	7.46e-05	0.00122	CbGpPWpGaD
Granisetron—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—liver cancer	7.1e-05	0.00116	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	7.1e-05	0.00116	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—GSTP1—liver cancer	6.96e-05	0.00114	CbGpPWpGaD
Granisetron—CYP2D6—Metapathway biotransformation—GSTP1—liver cancer	6.86e-05	0.00112	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—HPGDS—liver cancer	6.76e-05	0.00111	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—ALB—liver cancer	6.75e-05	0.00111	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—GSTM1—liver cancer	6.39e-05	0.00105	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—UGDH—liver cancer	6.37e-05	0.00104	CbGpPWpGaD
Granisetron—CYP2D6—Metapathway biotransformation—GSTM1—liver cancer	6.3e-05	0.00103	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—RAF1—liver cancer	6.11e-05	0.001	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—CYP1A1—liver cancer	6.06e-05	0.000993	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	6.04e-05	0.000989	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—UGDH—liver cancer	6.02e-05	0.000986	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—EPT1—liver cancer	5.99e-05	0.000982	CbGpPWpGaD
Granisetron—CYP2D6—Metapathway biotransformation—CYP1A1—liver cancer	5.98e-05	0.000979	CbGpPWpGaD
Granisetron—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—liver cancer	5.87e-05	0.000961	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—TAT—liver cancer	5.68e-05	0.000931	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—EPT1—liver cancer	5.66e-05	0.000927	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—CYP2E1—liver cancer	5.51e-05	0.000903	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	5.44e-05	0.000891	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—TAT—liver cancer	5.37e-05	0.000879	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	5.28e-05	0.000865	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—GGT1—liver cancer	5.06e-05	0.000829	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—GSTP1—liver cancer	4.55e-05	0.000745	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—UGDH—liver cancer	4.53e-05	0.000742	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	4.49e-05	0.000735	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—EPT1—liver cancer	4.26e-05	0.000698	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—GSTM1—liver cancer	4.18e-05	0.000685	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	4.12e-05	0.000675	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—TAT—liver cancer	4.04e-05	0.000662	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—CYP1A1—liver cancer	3.96e-05	0.000649	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	3.95e-05	0.000647	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	3.91e-05	0.00064	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GLUL—liver cancer	3.86e-05	0.000633	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CPT1B—liver cancer	3.86e-05	0.000633	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—NR1H4—liver cancer	3.72e-05	0.00061	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GSTA3—liver cancer	3.66e-05	0.0006	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GLUL—liver cancer	3.65e-05	0.000598	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CPT1B—liver cancer	3.65e-05	0.000598	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—NR1H4—liver cancer	3.52e-05	0.000576	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GSTA3—liver cancer	3.46e-05	0.000567	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GSTA4—liver cancer	3.35e-05	0.000548	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GSTA2—liver cancer	3.26e-05	0.000534	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GSTA4—liver cancer	3.16e-05	0.000518	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GSTA1—liver cancer	3.15e-05	0.000516	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—NAT2—liver cancer	3.11e-05	0.00051	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GSTA2—liver cancer	3.08e-05	0.000505	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ALDOB—liver cancer	2.98e-05	0.000489	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GSTA1—liver cancer	2.97e-05	0.000487	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—UGDH—liver cancer	2.96e-05	0.000485	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—NAT2—liver cancer	2.94e-05	0.000482	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CRABP1—liver cancer	2.85e-05	0.000466	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.83e-05	0.000463	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ALDOB—liver cancer	2.82e-05	0.000462	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—EPT1—liver cancer	2.79e-05	0.000456	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GLUL—liver cancer	2.75e-05	0.00045	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CPT1B—liver cancer	2.75e-05	0.00045	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CRABP1—liver cancer	2.69e-05	0.000441	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—NR1H4—liver cancer	2.65e-05	0.000434	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—TAT—liver cancer	2.64e-05	0.000433	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GSTA3—liver cancer	2.6e-05	0.000426	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—HPGDS—liver cancer	2.49e-05	0.000408	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.42e-05	0.000397	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GSTA4—liver cancer	2.38e-05	0.00039	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—HPGDS—liver cancer	2.35e-05	0.000385	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.34e-05	0.000383	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GSTA2—liver cancer	2.32e-05	0.00038	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GSTA1—liver cancer	2.24e-05	0.000367	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PSMA4—liver cancer	2.22e-05	0.000363	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PSMD10—liver cancer	2.22e-05	0.000363	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—NAT2—liver cancer	2.21e-05	0.000363	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GOT2—liver cancer	2.16e-05	0.000353	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.13e-05	0.000349	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ALDOB—liver cancer	2.12e-05	0.000348	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.1e-05	0.000344	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PSMA4—liver cancer	2.1e-05	0.000343	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PSMD10—liver cancer	2.1e-05	0.000343	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GOT2—liver cancer	2.04e-05	0.000334	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CYP2E1—liver cancer	2.03e-05	0.000332	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CRABP1—liver cancer	2.02e-05	0.000332	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CYP2E1—liver cancer	1.92e-05	0.000314	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CYCS—liver cancer	1.9e-05	0.000311	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GGT1—liver cancer	1.86e-05	0.000305	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GOT1—liver cancer	1.86e-05	0.000305	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.86e-05	0.000304	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GLUL—liver cancer	1.8e-05	0.000294	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CPT1B—liver cancer	1.8e-05	0.000294	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CYCS—liver cancer	1.79e-05	0.000294	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—HPGDS—liver cancer	1.77e-05	0.00029	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GOT1—liver cancer	1.76e-05	0.000288	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GGT1—liver cancer	1.76e-05	0.000288	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—NR1H4—liver cancer	1.73e-05	0.000284	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GSTA3—liver cancer	1.7e-05	0.000279	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GSTP1—liver cancer	1.67e-05	0.000274	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—HMOX1—liver cancer	1.65e-05	0.00027	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GSTP1—liver cancer	1.58e-05	0.000259	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PSMD10—liver cancer	1.58e-05	0.000258	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PSMA4—liver cancer	1.58e-05	0.000258	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—HMOX1—liver cancer	1.56e-05	0.000255	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GSTA4—liver cancer	1.56e-05	0.000255	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GSTM1—liver cancer	1.54e-05	0.000252	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GOT2—liver cancer	1.53e-05	0.000251	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GSTA2—liver cancer	1.52e-05	0.000248	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GSTA1—liver cancer	1.46e-05	0.00024	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CYP1A1—liver cancer	1.46e-05	0.000239	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GSTM1—liver cancer	1.45e-05	0.000238	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—NAT2—liver cancer	1.45e-05	0.000237	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CYP2E1—liver cancer	1.44e-05	0.000236	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ALDOB—liver cancer	1.39e-05	0.000227	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—MTHFR—liver cancer	1.36e-05	0.000223	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CYCS—liver cancer	1.35e-05	0.000221	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PPARA—liver cancer	1.33e-05	0.000218	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GGT1—liver cancer	1.32e-05	0.000217	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GOT1—liver cancer	1.32e-05	0.000217	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CRABP1—liver cancer	1.32e-05	0.000217	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—MTHFR—liver cancer	1.28e-05	0.00021	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PPARA—liver cancer	1.26e-05	0.000206	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GSTP1—liver cancer	1.19e-05	0.000195	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—HMOX1—liver cancer	1.17e-05	0.000192	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—HPGDS—liver cancer	1.16e-05	0.000189	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PIK3CG—liver cancer	1.14e-05	0.000187	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.13e-05	0.000185	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PPARG—liver cancer	1.1e-05	0.00018	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GSTM1—liver cancer	1.09e-05	0.000179	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PIK3CG—liver cancer	1.08e-05	0.000177	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PPARG—liver cancer	1.04e-05	0.00017	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CYP1A1—liver cancer	1.04e-05	0.00017	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PSMA4—liver cancer	1.03e-05	0.000169	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PSMD10—liver cancer	1.03e-05	0.000169	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PIK3CD—liver cancer	1e-05	0.000164	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GOT2—liver cancer	1e-05	0.000164	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ALB—liver cancer	9.91e-06	0.000162	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—MTHFR—liver cancer	9.66e-06	0.000158	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PIK3CD—liver cancer	9.48e-06	0.000155	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PPARA—liver cancer	9.48e-06	0.000155	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CYP2E1—liver cancer	9.43e-06	0.000154	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ALB—liver cancer	9.36e-06	0.000153	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CYCS—liver cancer	8.82e-06	0.000145	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PIK3CB—liver cancer	8.75e-06	0.000143	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GGT1—liver cancer	8.66e-06	0.000142	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GOT1—liver cancer	8.66e-06	0.000142	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PIK3CB—liver cancer	8.26e-06	0.000135	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PIK3CG—liver cancer	8.12e-06	0.000133	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PPARG—liver cancer	7.83e-06	0.000128	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GSTP1—liver cancer	7.78e-06	0.000127	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—HMOX1—liver cancer	7.67e-06	0.000126	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GSTM1—liver cancer	7.15e-06	0.000117	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PIK3CD—liver cancer	7.14e-06	0.000117	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ALB—liver cancer	7.04e-06	0.000115	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CYP1A1—liver cancer	6.78e-06	0.000111	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—MTHFR—liver cancer	6.32e-06	0.000103	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PIK3CB—liver cancer	6.22e-06	0.000102	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PPARA—liver cancer	6.2e-06	0.000102	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PIK3CA—liver cancer	5.33e-06	8.73e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PIK3CG—liver cancer	5.31e-06	8.69e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PPARG—liver cancer	5.12e-06	8.39e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PIK3CA—liver cancer	5.04e-06	8.25e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PIK3CD—liver cancer	4.67e-06	7.64e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ALB—liver cancer	4.61e-06	7.54e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—AKT1—liver cancer	4.36e-06	7.14e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—AKT1—liver cancer	4.12e-06	6.74e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PIK3CB—liver cancer	4.07e-06	6.66e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PIK3CA—liver cancer	3.79e-06	6.21e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—AKT1—liver cancer	3.1e-06	5.07e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PIK3CA—liver cancer	2.48e-06	4.06e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—AKT1—liver cancer	2.03e-06	3.32e-05	CbGpPWpGaD
